.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Chubb
McKesson
Julphar
Cantor Fitzgerald
Express Scripts
Boehringer Ingelheim
Merck
Moodys
QuintilesIMS

Generated: December 16, 2017

DrugPatentWatch Database Preview

KOVANAZE Drug Profile

« Back to Dashboard

Which patents cover Kovanaze, and when can generic versions of Kovanaze launch?

Kovanaze is a drug marketed by St Renatus and is included in one NDA. There are three patents protecting this drug.

This drug has twenty-two patent family members in thirteen countries.

The generic ingredient in KOVANAZE is oxymetazoline hydrochloride; tetracaine hydrochloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the oxymetazoline hydrochloride; tetracaine hydrochloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
St RenatusKOVANAZEoxymetazoline hydrochloride; tetracaine hydrochlorideSPRAY, METERED;NASAL208032-001Jun 29, 2016RXYesYes► Subscribe► SubscribeY► Subscribe
St RenatusKOVANAZEoxymetazoline hydrochloride; tetracaine hydrochlorideSPRAY, METERED;NASAL208032-001Jun 29, 2016RXYesYes► Subscribe► Subscribe► Subscribe
St RenatusKOVANAZEoxymetazoline hydrochloride; tetracaine hydrochlorideSPRAY, METERED;NASAL208032-001Jun 29, 2016RXYesYes► Subscribe► Subscribe► Subscribe
St RenatusKOVANAZEoxymetazoline hydrochloride; tetracaine hydrochlorideSPRAY, METERED;NASAL208032-001Jun 29, 2016RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: KOVANAZE

Country Document Number Estimated Expiration
Eurasian Patent Organization024184► Subscribe
European Patent Office2413899► Subscribe
Eurasian Patent Organization201171215► Subscribe
Israel215489► Subscribe
China103932973► Subscribe
South Africa201107011► Subscribe
Canada2757032► Subscribe
Japan2012522783► Subscribe
China102421416► Subscribe
South Korea20170026639► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Johnson and Johnson
Boehringer Ingelheim
Chubb
Queensland Health
Cipla
US Department of Justice
Deloitte
Cantor Fitzgerald
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot